Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene

被引:36
|
作者
Hao, Le T. [1 ,2 ]
Burghes, Arthur H. M. [3 ]
Beattie, Christine E. [1 ,2 ]
机构
[1] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
来源
MOLECULAR NEURODEGENERATION | 2011年 / 6卷
关键词
SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; NEUROMUSCULAR-JUNCTIONS; TRANSGENIC ZEBRAFISH; SINGLE NUCLEOTIDE; AXON OUTGROWTH; PROTEIN; MICE; IDENTIFICATION;
D O I
10.1186/1750-1326-6-24
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Animal models of human diseases are essential as they allow analysis of the disease process at the cellular level and can advance therapeutics by serving as a tool for drug screening and target validation. Here we report the development of a complete genetic model of spinal muscular atrophy (SMA) in the vertebrate zebrafish to complement existing zebrafish, mouse, and invertebrate models and show its utility for testing compounds that alter SMN2 splicing. Results: The human motoneuron disease SMA is caused by low levels, as opposed to a complete absence, of the survival motor neuron protein (SMN). To generate a true model of SMA in zebrafish, we have generated a transgenic zebrafish expressing the human SMN2 gene (hSMN2), which produces only a low amount of full-length SMN, and crossed this onto the smn(-/-) background. We show that human SMN2 is spliced in zebrafish as it is in humans and makes low levels of SMN protein. Moreover, we show that an antisense oligonucleotide that enhances correct hSMN2 splicing increases full-length hSMN RNA in this model. When we placed this transgene on the smn mutant background it rescued the neuromuscular presynaptic SV2 defect that occurs in smn mutants and increased their survival. Conclusions: We have generated a transgenic fish carrying the human hSMN2 gene. This gene is spliced in fish as it is in humans and mice suggesting a conserved splicing mechanism in these vertebrates. Moreover, antisense targeting of an intronic splicing silencer site increased the amount of full length SMN generated from this transgene. Having this transgene on the smn mutant fish rescued the presynaptic defect and increased survival. This model of zebrafish SMA has all of the components of human SMA and can thus be used to understand motoneuron dysfunction in SMA, can be used as an vivo test for drugs or antisense approaches that increase full-length SMN, and can be developed for drug screening.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2gene
    Le T Hao
    Arthur HM Burghes
    Christine E Beattie
    Molecular Neurodegeneration, 6
  • [2] A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotype
    Gladman, Jordan T.
    Bebee, Thomas W.
    Edwards, Chris
    Wang, Xueyong
    Sahenk, Zarife
    Rich, Mark M.
    Chandler, Dawn S.
    HUMAN MOLECULAR GENETICS, 2010, 19 (21) : 4239 - 4252
  • [3] Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype
    Ruhno, Corey
    McGovern, Vicki L.
    Avenarius, Matthew R.
    Snyder, Pamela J.
    Prior, Thomas W.
    Nery, Flavia C.
    Muhtaseb, Abdurrahman
    Roggenbuck, Jennifer S.
    Kissel, John T.
    Sansone, Valeria A.
    Siranosian, Jennifer J.
    Johnstone, Alec J.
    Nwe, Pann H.
    Zhang, Ren Z.
    Swoboda, Kathryn J.
    Burghes, Arthur H. M.
    HUMAN GENETICS, 2019, 138 (03) : 241 - 256
  • [4] Hypoxia is a modifier of SMN2 splicing and disease severity in a severe SMA mouse model
    Bebee, Thomas W.
    Dominguez, Catherine E.
    Samadzadeh-Tarighat, Somayeh
    Akehurst, Kristi L.
    Chandler, Dawn S.
    HUMAN MOLECULAR GENETICS, 2012, 21 (19) : 4301 - 4313
  • [5] Pathological impact of SMN2 mis-splicing in adult SMA mice
    Sahashi, Kentaro
    Ling, Karen K. Y.
    Hua, Yimin
    Wilkinson, John Erby
    Nomakuchi, Tomoki
    Rigo, Frank
    Hung, Gene
    Xu, David
    Jiang, Ya-Ping
    Lin, Richard Z.
    Ko, Chien-Ping
    Bennett, C. Frank
    Krainer, Adrian R.
    EMBO MOLECULAR MEDICINE, 2013, 5 (10) : 1586 - 1601
  • [6] Bone loss in survival motor neuron (Smn-/- SMN2) genetic mouse model of spinal muscular atrophy
    Shanmugarajan, Srinivasan
    Tsuruga, Eichi
    Swoboda, Kathryn J.
    Maria, Bernard L.
    Ries, William L.
    Reddy, Sakamuri V.
    JOURNAL OF PATHOLOGY, 2009, 219 (01) : 52 - 60
  • [7] Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA
    Konieczny, Piotr
    Artero, Ruben
    FASEB JOURNAL, 2020, 34 (02) : 3021 - 3036
  • [8] Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
    Hua, Yimin
    Sahashi, Kentaro
    Hung, Gene
    Rigo, Frank
    Passini, Marco A.
    Bennett, C. Frank
    Krainer, Adrian R.
    GENES & DEVELOPMENT, 2010, 24 (15) : 1634 - 1644
  • [9] A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice
    Workman, Eileen
    Saieva, Luciano
    Carrel, Tessa L.
    Crawford, Thomas O.
    Liu, Don
    Lutz, Cathleen
    Beattie, Christine E.
    Pellizzoni, Livio
    Burghes, Arthur H. M.
    HUMAN MOLECULAR GENETICS, 2009, 18 (12) : 2215 - 2229
  • [10] Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology
    Wang, Yiran
    Xu, Chongchong
    Ma, Lin
    Mou, Yongchao
    Zhang, Bowen
    Zhou, Shanshan
    Tian, Yue
    Trinh, Jessica
    Zhang, Xiaoqing
    Li, Xue-Jun
    LIFE SCIENCE ALLIANCE, 2019, 2 (02)